149 related articles for article (PubMed ID: 6880764)
1. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
Gábor M
Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
[No Abstract] [Full Text] [Related]
2. Anticatatonic effect of venoruton.
Aley KO; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
[TBL] [Abstract][Full Text] [Related]
3. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
Gábor M
Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
[TBL] [Abstract][Full Text] [Related]
4. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
Dobbins DE; Soika CY; Dabney JM
Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
[TBL] [Abstract][Full Text] [Related]
5. [Venoruton and capillary permeability].
Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
[TBL] [Abstract][Full Text] [Related]
6. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
[No Abstract] [Full Text] [Related]
7. Venoruton in the therapy of central retinal vein occlusion.
Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
[No Abstract] [Full Text] [Related]
8. [Treatment of sudden deafness of vascular etiology with venoruton].
Madej S
Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
[TBL] [Abstract][Full Text] [Related]
9. New pharmacological and clinical properties of the venoactive agent: Venoruton (Paroven). Studies presented at the 1st Mediterranean Congress of Angiology. Corfu, Greece, May 29 to June 3, 1988. Abstracts.
Int Angiol; 1988; 7(4 Suppl):1-16. PubMed ID: 3249081
[No Abstract] [Full Text] [Related]
10. Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry.
Belcaro G; D'Aulerio A; Rulo A; Candiani C
Phlebologie; 1988; 41(4):847-56. PubMed ID: 3073400
[TBL] [Abstract][Full Text] [Related]
11. Effects of Troxerutin on the hemorheological parameters of patients with moderate arterial hypertension.
Gueguen-Duchesne M; Durand F; Le Goff MC; Genetet B
Prog Clin Biol Res; 1988; 280():401-6. PubMed ID: 3174703
[No Abstract] [Full Text] [Related]
12. Effect of Venoruton on the factor XIII activity in rat plasma.
Grochal M; Sempińska-Edelberg E; Plewiński J
Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
[TBL] [Abstract][Full Text] [Related]
13. Effects of Venoruton on early postradiation damage in the lungs of rats.
Starosławska E; Donica H; Sobolewski K; Floriańczyk B; Grzybowska-Szatkowska LA; Krzyzanowski K
Rocz Akad Med Bialymst; 1998; 43():95-109. PubMed ID: 9972046
[TBL] [Abstract][Full Text] [Related]
14. Effect of dose schedule of vitamin E and hydroxethylruticide on intestinal toxicity induced by adriamycin.
McGinness JE; Grossie B; Proctor PH; Benjamin RS; Gulati OP; Hokanson JA
Physiol Chem Phys Med NMR; 1986; 18(1):17-24. PubMed ID: 3774891
[TBL] [Abstract][Full Text] [Related]
15. [Critical study of the therapeutic effects of phlebotropic drugs on chronic venous insufficiency].
Roztocil K; Prerovsky I; Oliva I
Phlebologie; 1979; 32(4):395-8. PubMed ID: 120945
[TBL] [Abstract][Full Text] [Related]
16. [Anti-edema activity of injectable Venoruton in abdominal surgery].
De Anna D; Liboni A; Paoli M; Pollinzi V; Malin L; Mannella P; Ambroso G; Oberhauser V
Minerva Chir; 1979 Oct; 34(20):1377-92. PubMed ID: 503345
[TBL] [Abstract][Full Text] [Related]
17. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
[No Abstract] [Full Text] [Related]
18. Protective effects of O-(beta-hydroxyethyl)-rutosides (HR) against adriamycin-induced toxicity in rats.
Gulati OP; Nordmann H; Aellig A; Maignan MF; McGinness J
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):323-34. PubMed ID: 4004421
[TBL] [Abstract][Full Text] [Related]
19. Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils.
Shukla VK; Sethi AK; Garg SK; Ganguly NK; Kulkarni SK
Arch Int Pharmacodyn Ther; 1989; 299():127-33. PubMed ID: 2774763
[TBL] [Abstract][Full Text] [Related]
20. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
Matagne D; Hamoir G
Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
